• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性甲状腺癌中的雌激素:术前和术后病例尿液谱的改变。

Estrogens in female thyroid cancer: alteration of urinary profiles in pre- and post-operative cases.

作者信息

Lee Seon Hwa, Kim Kyung Mee, Jung Byung Hwa, Chung Woung Youn, Park Cheong Soo, Chung Bong Chul

机构信息

Bioanalysis and Biotransformation Research Center, Korea Institute of Science and Technology, P.O. Box 131, Cheongryang, Seoul, 130-650, South Korea.

出版信息

Cancer Lett. 2003 Jan 10;189(1):27-32. doi: 10.1016/s0304-3835(02)00514-1.

DOI:10.1016/s0304-3835(02)00514-1
PMID:12445674
Abstract

To evaluate the potential effect of estrogens in premenopausal female thyroid cancer, the concentrations of 14 estrogens were quantitatively determined in the urine of pre- and post-operative patients with thyroid papillary cancer (18 patients case, 26 approximately 54 years) and normal female subjects (20 cases, 31 approximately 52 years). The highly sensitive gas chromatography-mass spectrometry-selected ion-monitoring method was used for estrogens analysis. And an estrogen-oxidative metabolism and 16alpha-hydroxyestrone to 2-hydroxyestrone (16alpha-OH E1/2-OH E1) which is the two primary and competing site of estrogen-oxidation, were determined. Catechol estrogens, including 2-OH E1, were also increased without significant changes of the other estrogen metabolites in pre-operative patients with thyroid papillary cancer compared with normal subjects. The lowest mean value of 16alpha-OH E1/2-OH E1 was remarked in pre-operative patients, and it was significantly different from the ratio of post-operative cases. As a result, it is suggested that the increase of 2-hydroxylation in estrogen metabolism may have a significant association with female thyroid cancer.

摘要

为评估雌激素对绝经前女性甲状腺癌的潜在影响,采用高灵敏度气相色谱 - 质谱选择离子监测法,对甲状腺乳头状癌患者(18例,年龄约54岁)手术前后及正常女性受试者(20例,年龄约52岁)尿液中的14种雌激素进行定量测定,并测定雌激素氧化代谢及雌激素氧化的两个主要竞争位点——16α - 羟基雌酮与2 - 羟基雌酮(16α - OH E1/2 - OH E1)的比值。与正常受试者相比,甲状腺乳头状癌术前患者中儿茶酚雌激素(包括2 - OH E1)增加,而其他雌激素代谢产物无显著变化。术前患者的16α - OH E1/2 - OH E1比值最低,且与术后病例的比值有显著差异。结果表明,雌激素代谢中2 - 羟化作用的增强可能与女性甲状腺癌有显著关联。

相似文献

1
Estrogens in female thyroid cancer: alteration of urinary profiles in pre- and post-operative cases.女性甲状腺癌中的雌激素:术前和术后病例尿液谱的改变。
Cancer Lett. 2003 Jan 10;189(1):27-32. doi: 10.1016/s0304-3835(02)00514-1.
2
Metabolic alteration of urinary steroids in pre- and post-menopausal women, and men with papillary thyroid carcinoma.绝经前和绝经后妇女以及患有甲状腺乳头癌的男性的尿甾体代谢改变。
BMC Cancer. 2011 Aug 8;11:342. doi: 10.1186/1471-2407-11-342.
3
A hormonal association between estrogen metabolism and proliferative thyroid disease.雌激素代谢与增殖性甲状腺疾病之间的激素关联。
Otolaryngol Head Neck Surg. 2006 Jun;134(6):893-900. doi: 10.1016/j.otohns.2006.01.020.
4
Estrogens and polyamines in breast cancer: their profiles and values in disease staging.乳腺癌中的雌激素和多胺:它们在疾病分期中的特征及价值。
Cancer Lett. 1998 Nov 13;133(1):47-56. doi: 10.1016/s0304-3835(98)00189-x.
5
The 2-/16α-Hydroxylated Estrogen Ratio-Breast Cancer Risk Hypothesis: Insufficient Evidence for its Support.2-/16α-羟化雌激素比值-乳腺癌风险假说:支持该假说的证据不足。
J Steroid Biochem Mol Biol. 2020 Jul;201:105685. doi: 10.1016/j.jsbmb.2020.105685. Epub 2020 Apr 19.
6
Reproducibility over time of measurements of androgens, estrogens and hydroxy estrogens in urine samples from post-menopausal women.绝经后女性尿液样本中雄激素、雌激素和羟基雌激素测量值随时间的可重复性。
Eur J Epidemiol. 2003;18(5):417-24. doi: 10.1023/a:1024209122412.
7
Soy protein isolate increases urinary estrogens and the ratio of 2:16alpha-hydroxyestrone in men at high risk of prostate cancer.
J Nutr. 2007 Oct;137(10):2258-63. doi: 10.1093/jn/137.10.2258.
8
Altered hydroxylation of estrogen in patients with postmenopausal osteopenia.绝经后骨质减少患者雌激素羟基化改变。
J Clin Endocrinol Metab. 1997 Apr;82(4):1001-6. doi: 10.1210/jcem.82.4.3875.
9
Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection.尿雌激素代谢物与乳腺癌:治疗前与治疗后收集样本发现的不同风险模式。
Steroids. 2003 Jan;68(1):65-72. doi: 10.1016/s0039-128x(02)00116-2.
10
Menstrual cycle effects on urinary estrogen metabolites.月经周期对尿雌激素代谢物的影响。
J Clin Endocrinol Metab. 1999 Nov;84(11):3914-8. doi: 10.1210/jcem.84.11.6134.

引用本文的文献

1
Oncometabolites as biomarkers in thyroid cancer: a systematic review.癌代谢物作为甲状腺癌生物标志物的系统评价
Cancer Manag Res. 2019 Feb 25;11:1829-1841. doi: 10.2147/CMAR.S188661. eCollection 2019.
2
A novel GC-MS method in urinary estrogen analysis from postmenopausal women with osteoporosis.一种用于分析绝经后骨质疏松症妇女尿液中雌激素的新型 GC-MS 方法。
J Lipid Res. 2011 Aug;52(8):1595-603. doi: 10.1194/jlr.D016113. Epub 2011 May 21.